These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3942725)

  • 21. Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemagglutinin with red blood cells.
    Krumbiegel M; Dimitrov DS; Puri A; Blumenthal R
    Biochim Biophys Acta; 1992 Oct; 1110(2):158-64. PubMed ID: 1390844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene homology and antigenic specificity of envelope proteins of avian influenza virus strains possessing haemagglutinin Havl.
    Markushin SG; Isachenko VA; Molibog EV; Zakstelskaya LYa ; Ghendon YuZ
    Acta Virol; 1981 Mar; 25(2):65-70. PubMed ID: 6166185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of morphological, biological and antigenic properties of avian influenza A virus haemagglutinin H2 in the course of adaptation to new host.
    Lipatov AS; Gitelman AK; Govorkova EA; Smirnov YuA
    Acta Virol; 1995 Dec; 39(5-6):279-81. PubMed ID: 8722298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid peroxidation decreases the rotational mobility of cytochrome P-450 in rat liver microsomes.
    Gut J; Kawato S; Cherry RJ; Winterhalter KH; Richter C
    Biochim Biophys Acta; 1985 Jul; 817(2):217-28. PubMed ID: 3925992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B.K. virus haemagglutinin.
    Kende M; Uj M; Szücs G
    Acta Microbiol Acad Sci Hung; 1979; 26(3):179-84. PubMed ID: 44428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of rimantadine on the structure of influenza A virus haemagglutinin.
    Mikheeva AV; Melnikov AYa ; Anisimova E
    Acta Virol; 1989 Mar; 33(2):131-6. PubMed ID: 2569808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient domains induced by influenza haemagglutinin during membrane fusion.
    Blumenthal R; Pak CC; Raviv Y; Krumbiegel M; Bergelson LD; Morris SJ; Lowy RJ
    Mol Membr Biol; 1995; 12(1):135-42. PubMed ID: 7767373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the morphology of influenza particles induced at low pH.
    Ruigrok RW; Cremers AF; Beyer WE; de Ronde-Verloop FM
    Arch Virol; 1984; 82(3-4):181-94. PubMed ID: 6508530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural changes in influenza virus haemagglutinin at the pH of membrane fusion.
    Skehel JJ; Daniels RS; Hay AJ; Ruigrok R; Wharton SA; Wrigley NG; Weiss W; Willey DC
    Biochem Soc Trans; 1986 Apr; 14(2):252-3. PubMed ID: 3709949
    [No Abstract]   [Full Text] [Related]  

  • 30. Membrane fusion by peptide analogues of influenza virus haemagglutinin.
    Wharton SA; Martin SR; Ruigrok RW; Skehel JJ; Wiley DC
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1847-57. PubMed ID: 3404116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low resolution structure of the influenza C glycoprotein determined by electron microscopy.
    Hewat EA; Cusack S; Ruigrok RW; Verwey C
    J Mol Biol; 1984 May; 175(2):175-93. PubMed ID: 6726808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor.
    Herrler G; Dürkop I; Becht H; Klenk HD
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():839-46. PubMed ID: 3356980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2.
    Maeda T; Kawasaki K; Ohnishi S
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4133-7. PubMed ID: 6945575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological changes and fusogenic activity of influenza virus hemagglutinin.
    Shangguan T; Siegel DP; Lear JD; Axelsen PH; Alford D; Bentz J
    Biophys J; 1998 Jan; 74(1):54-62. PubMed ID: 9449309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material.
    Luykx DM; Casteleijn MG; Jiskoot W; Westdijk J; Jongen PM
    Eur J Pharm Sci; 2004 Sep; 23(1):65-75. PubMed ID: 15324924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2.
    Kostolanský F; Styk B; Russ G
    Acta Virol; 1989 Dec; 33(6):504-12. PubMed ID: 2576592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayers.
    Epand RM; Epand RF
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1420-5. PubMed ID: 8060322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.
    Skehel JJ; Bayley PM; Brown EB; Martin SR; Waterfield MD; White JM; Wilson IA; Wiley DC
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):968-72. PubMed ID: 6951181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of influenza virus neuraminidase with hemagglutinin activity and its comparison with that of viral neuraminidase.
    Arora DJ; Gabriel LF
    Biochim Biophys Acta; 1986 Oct; 884(1):73-83. PubMed ID: 3533157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.